The last four years for pharmaceutical wholesalers have been tough, uncertain demand and outcomes, bumpy supply chains, uncertain of the changes in regulations ahead, staff shortages have added to the risks already in the business model.
People often tell us that they cannot audit when they come on our course. This is not true they must just look at things differently. They must do their homework to ensure that they know what they are auditing and why.
Deadline approaching – Medical Device Registration for registering Class IIa and Class IIb (other than implants) products with the MHRA is the end of August 2021.
Remote Auditing versus On Site Auditing: For the last 16 months the pharmaceutical world has had to get used to remote auditing as opposed to auditing in person.
Following Brexit and GB leaving the EU the MHRA have advised that GB wholesale dealers now need to appoint an RPi
As Great Britain (GB) are no longer part of the European Union (EU) since the 1st of January 2021 exit date. It is essential to ensure all the necessary changes have been made to remain MHRA compliant.
